Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...
Transferrin receptor 1 (TfR1) has been shown to be upregulated in nasopharyngeal carcinoma (NPC). Here the authors report that TfR1 can be targeted in hypoxic NPC lesions using ferritin nanozymes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback